Similar to NEAT1 in breast cancer, the c-Myc-responsive lncRNA glycoLINC (gLINC) promotes glycolysis by acting as a scaffold for glycolytic enzymes, including PGK1, ENO1, PKM2, and LDHA, with indirect binding to PGAM1. Here, ENO1 is linked to breast cancer.